Literature DB >> 3001812

Hepatocellular carcinoma: one of the world's most common malignancies.

G C Cook.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 3001812

Source DB:  PubMed          Journal:  Q J Med        ISSN： 0033-5622


× No keyword cloud information.
  11 in total

Review 1.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

2.  Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma.

Authors:  Zhi-xiang Yang; Dong Wang; Ge Wang; Qin-hong Zhang; Jing-mao Liu; Po Peng; Xiao-hui Liu
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-31       Impact factor: 4.553

3.  Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma.

Authors:  Jerzy Kaczynski; Göran Hansson; Sven Wallerstedt
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

4.  Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.

Authors:  Shinji Sugahara; Hidetsugu Nakayama; Kuniaki Fukuda; Masashi Mizumoto; Mari Tokita; Masato Abei; Junichi Shoda; Yasushi Matsuzaki; Eriko Thono; Koji Tsuboi; Koichi Tokuuye
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

5.  Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma.

Authors:  Chen-Hsi Hsieh; Chia-Yuan Liu; Pei-Wei Shueng; Ngot-Swan Chong; Chih-Jen Chen; Ming-Jen Chen; Ching-Chung Lin; Tsang-En Wang; Shee-Chan Lin; Hung-Chi Tai; Hui-Ju Tien; Kuo-Hsin Chen; Li-Ying Wang; Yen-Ping Hsieh; David Y C Huang; Yu-Jen Chen
Journal:  Radiat Oncol       Date:  2010-05-23       Impact factor: 3.481

6.  Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma.

Authors:  Kavous Firouznia; Hossein Ghanaati; Seyed Moayed Alavian; Payam Azadeh; Mohsen Nasiri Toosi; Arya Haj Mirzaian; Safa Najafi; Madjid Shakiba; Amir Hossein Jalali
Journal:  Hepat Mon       Date:  2014-12-28       Impact factor: 0.660

7.  Retracted article: In vitro derivation of mammalian germ cells from stem cells and their potential therapeutic application.

Authors:  Shigeo Saito; Ying-Chu Lin; Yoshinobu Murayama; Yukio Nakamura; Richard Eckner; Heiner Niemann; Kazunari K Yokoyama
Journal:  Cell Mol Life Sci       Date:  2015-10-06       Impact factor: 9.261

8.  Acute hepatic porphyria and hepatocellular carcinoma.

Authors:  R Kauppinen; P Mustajoki
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

9.  Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area.

Authors:  J Kaczynski; G Hansson; S Wallerstedt
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

10.  Ambovex(®) as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial.

Authors:  Hosny Salama; Hassan Ahmad; Ismail Elchagea; Abdel Rahman Zekri; Eman Medhat; Abeer Bahnassy; Michael Lange; Mohammed Rabbat; Andrew N de la Torre; Pravin Punamiya
Journal:  J Hepatocell Carcinoma       Date:  2015-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.